Colony Bankcorp vs Eagle Bancorp Montana
CBAN and EBMT side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CBAN and EBMT compare
Colony Bankcorp is the larger company, worth 2.6 times as much as Eagle Bancorp Montana ($433M against $163M).
Colony Bankcorp grew revenue faster over the last twelve months (28.1% versus 9.6% for Eagle Bancorp Montana).
Eagle Bancorp Montana keeps more of each dollar of sales as profit, with a net margin of 15.9% compared with 9.8% at Colony Bankcorp.
Both pay dividends: Colony Bankcorp yields 1.8% and Eagle Bancorp Montana 2.8%.
Eagle Bancorp Montana scores higher on the StockData Score (15 against 10 for Colony Bankcorp), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CBAN | EBMT |
|---|---|---|
| Size and price | ||
| Market cap | $433M | $163M |
| Share price | $20.39 | $20.51 |
| Change, 1 year | 26.3% | 23.6% |
| Change, 5 years | 10.0% | −8.1% |
| Beta (5Y) | 0.57 | 0.37 |
| Employees | 537 | 279 |
| StockData Score | ||
| Total score | 10 | 15 (better) |
| Valuation score | 2 | 5 (better) |
| Growth score | 1 | 1 |
| Performance score | 0 | 1 (better) |
| Health score | 4 | 4 |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | – | 10.5× |
| P/S | 2.7× | 1.7× (better) |
| P/B | 1.1× | 0.9× (better) |
| P/FCF | 35.0× | 7.7× (better) |
| PEG | – | 1.11 |
| FCF yield | 2.9% | 12.9% (better) |
| Fair value | – | $23.88 |
| Margin of safety | – | 14.1% |
| Growth | ||
| Revenue growth (TTM) | 28.1% (better) | 9.6% |
| Revenue growth, 5Y average | −17.7% | −0.15% (better) |
| Net income growth (TTM) | −43.3% | 14.1% (better) |
| EPS growth (TTM) | – | 14.0% |
| EPS growth, 5Y average | −21.1% | −9.4% (better) |
| Profitability | ||
| Net margin | 9.8% | 15.9% (better) |
| FCF margin | 7.7% | 21.7% (better) |
| Return on equity | 4.5% | 8.2% (better) |
| Financial health | ||
| Altman Z-score | 0.19 (better) | 0.16 |
| Piotroski F-score | 3 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.8% | 2.8% (better) |
| Payout ratio | 61.1% | 30.1% |
| Years of dividend growth | 0 | 5 (better) |
| Dividend growth, 5Y average | −22.1% | 8.4% (better) |
| Buyback yield | 0.59% (better) | 0.25% |
| Shareholder yield | 2.4% | 3.1% (better) |
| Ownership | ||
| Held by institutions | 60.6% | 53.8% |
| Held by insiders | 4.3% | 6.3% |
| Insider net buying, 12 months | $306K (better) | −$701K |
| Short interest, % of float | 6.5% | 2.5% |
Go deeper
- CBAN stock overview
- CBAN income statement
- CBAN valuation and score
- EBMT stock overview
- EBMT income statement
- EBMT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.